Alpha-1-Antichymotrypsin Antibody / AACT / SERPINA3

• Description:

  It recognizes a protein of 65-76kDa, which is identified antichymotrypsin (AACT). AACT is a plasma protease inhibitor synthesized in the liver as a single glycopeptide chain. In human, the normal serum level of AACT is about one-tenth that of their concentrations in plasma increase in response to trauma, surgery and infection. Elevated levels of AACT are widely, but not universally, reported in the cerebrospinal fluid and plasma of AD patients. Prostate-specific antigen (PSA) and its SDS-stable complex with AACT are in widespread use as markers for the diagnosis of prostate cancer. AACT deficiency may also be a possible cause of chronic liver disease. AACT antibody reacts with histiocytes and histiocytic neoplasms. It is widely used to identify histiocytes and tumors derived from them. Acinar tumors of the pancreas and salivary gland may also exhibit AACT positivity.

• UniProt:

  P01011

• Host:

  Mouse

• Immunogen:

  A portion of amino acids A portion of amino acids 49-187 was used as the immunogen for the Alpha-1-Antichymotrypsin antibody.

• Clonality:

  Monoclonal

• Isotype:

  IgG2a κ

• Applications:

  IHC-P

• Format:

  Purified

• Buffer:

  0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide

• Reconstitution:

  Aliquot the Alpha-1-Antichymotrypsin antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

• Limitations:

  This Alpha-1-Antichymotrypsin antibody is available for research use only.

• CAS Number:

  9007-83-4